Genor Biopharma (6998) Announces EGM to Vote on Proposed Merger, Whitewash Waiver, Share Capital Increase, and Name Change

Bulletin Express2025-12-04

Genor Biopharma Holdings Limited (the “Company,” Stock Code 6998) has issued a notice for an Extraordinary General Meeting (EGM) to be held on Monday, 22 December 2025, at 10:00 a.m. in Room 501-02, 5/F, Building 6, 690 Bibo Road, Pudong New District, Shanghai, China. According to the announcement dated 5 December 2025, shareholders will consider and vote on several key resolutions, including a proposed merger agreement entered into by the Company, a Merger Sub, and a Target.

The resolutions include the proposed allotment and issuance of consideration shares under a Specific Mandate, a Retention Plan subject to the consent of the Executive under Rule 25 of the Takeovers Code, and an increase in authorized share capital from US$20,000 to US$60,000. Shareholders will also vote on a One-off Share Option Plan, the Whitewash Waiver for Mr. Ni, and a name change of the Company from “Genor Biopharma Holdings Limited” to “Edding Genor Group Holdings Limited.” All resolutions at the EGM will be taken by poll in accordance with the Listing Rules.

The register of members will be closed from Thursday, 18 December 2025 to Monday, 22 December 2025 (both days inclusive). The announcement also provides details on proxy arrangements and the potential impact of adverse weather conditions on the EGM date. Further information is available in the Company’s published circular.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1195978577?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 22:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195978577","market":"hk","top_or_hot":-1,"title":"Genor Biopharma (6998) Announces EGM to Vote on Proposed Merger, Whitewash Waiver, Share Capital Increase, and Name Change","media":"Bulletin Express","content":"<p>Genor Biopharma Holdings Limited (the “Company,” Stock Code 6998) has issued a notice for an Extraordinary General Meeting (EGM) to be held on Monday, 22 December 2025, at 10:00 a.m. in Room 501-02, 5/F, Building 6, 690 Bibo Road, Pudong New District, Shanghai, China. According to the announcement dated 5 December 2025, shareholders will consider and vote on several key resolutions, including a proposed merger agreement entered into by the Company, a Merger Sub, and a Target.</p>\n<p>The resolutions include the proposed allotment and issuance of consideration shares under a Specific Mandate, a Retention Plan subject to the consent of the Executive under Rule 25 of the Takeovers Code, and an increase in authorized share capital from US$20,000 to US$60,000. Shareholders will also vote on a One-off Share Option Plan, the Whitewash Waiver for Mr. Ni, and a name change of the Company from “Genor Biopharma Holdings Limited” to “Edding Genor Group Holdings Limited.” All resolutions at the EGM will be taken by poll in accordance with the Listing Rules.</p>\n<p>The register of members will be closed from Thursday, 18 December 2025 to Monday, 22 December 2025 (both days inclusive). The announcement also provides details on proxy arrangements and the potential impact of adverse weather conditions on the EGM date. Further information is available in the Company’s published circular.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genor Biopharma (6998) Announces EGM to Vote on Proposed Merger, Whitewash Waiver, Share Capital Increase, and Name Change</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenor Biopharma (6998) Announces EGM to Vote on Proposed Merger, Whitewash Waiver, Share Capital Increase, and Name Change\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-04 22:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genor Biopharma Holdings Limited (the “Company,” Stock Code 6998) has issued a notice for an Extraordinary General Meeting (EGM) to be held on Monday, 22 December 2025, at 10:00 a.m. in Room 501-02, 5/F, Building 6, 690 Bibo Road, Pudong New District, Shanghai, China. According to the announcement dated 5 December 2025, shareholders will consider and vote on several key resolutions, including a proposed merger agreement entered into by the Company, a Merger Sub, and a Target.</p>\n<p>The resolutions include the proposed allotment and issuance of consideration shares under a Specific Mandate, a Retention Plan subject to the consent of the Executive under Rule 25 of the Takeovers Code, and an increase in authorized share capital from US$20,000 to US$60,000. Shareholders will also vote on a One-off Share Option Plan, the Whitewash Waiver for Mr. Ni, and a name change of the Company from “Genor Biopharma Holdings Limited” to “Edding Genor Group Holdings Limited.” All resolutions at the EGM will be taken by poll in accordance with the Listing Rules.</p>\n<p>The register of members will be closed from Thursday, 18 December 2025 to Monday, 22 December 2025 (both days inclusive). The announcement also provides details on proxy arrangements and the potential impact of adverse weather conditions on the EGM date. Further information is available in the Company’s published circular.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06998","symbol_name":"嘉和生物","start_time":0,"source_url":"","article_id":"1195978577","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195978577","pubTimestamp":1764859500,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Genor Biopharma Holdings Limited (the “Company,” Stock Code 6998) has issued a notice for an Extraordinary General Meeting (EGM) to be held on Monday, 22 December 2025, at 10:00 a.m. in Room 501-02,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06998":"嘉和生物"},"translate_title":"嘉和生物(6998)公布临时股东大会就建议合并、洗白豁免、增加股本及更改名称进行表决","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06998":1},"content_text":"Genor Biopharma Holdings Limited (the “Company,” Stock Code 6998) has issued a notice for an Extraordinary General Meeting (EGM) to be held on Monday, 22 December 2025, at 10:00 a.m. in Room 501-02, 5/F, Building 6, 690 Bibo Road, Pudong New District, Shanghai, China. According to the announcement dated 5 December 2025, shareholders will consider and vote on several key resolutions, including a proposed merger agreement entered into by the Company, a Merger Sub, and a Target.\nThe resolutions include the proposed allotment and issuance of consideration shares under a Specific Mandate, a Retention Plan subject to the consent of the Executive under Rule 25 of the Takeovers Code, and an increase in authorized share capital from US$20,000 to US$60,000. Shareholders will also vote on a One-off Share Option Plan, the Whitewash Waiver for Mr. Ni, and a name change of the Company from “Genor Biopharma Holdings Limited” to “Edding Genor Group Holdings Limited.” All resolutions at the EGM will be taken by poll in accordance with the Listing Rules.\nThe register of members will be closed from Thursday, 18 December 2025 to Monday, 22 December 2025 (both days inclusive). The announcement also provides details on proxy arrangements and the potential impact of adverse weather conditions on the EGM date. Further information is available in the Company’s published circular.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1195978577","isCrawlerRequest":true}